Ignite Creation Date:
2024-05-06 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06242171
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-05
First Post:
2024-01-27
Brief Title:
Prognostic Indices of Atheromatosis Severity and Coronary Artery Bypass Surgery Outcomes for Patients With Coronary Artery Disease
Sponsor:
Onassis Cardiac Surgery Centre
Organization:
Onassis Cardiac Surgery Centre
Study Overview
Official Title:
Prognostic Indices of Atheromatosis Severity and Coronary Artery Bypass Surgery Outcomes for Patients With Coronary Artery Disease
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Coronary artery disease is a multifactorial disease Traditional risk factors such as obesity diabetes hypertension stimulate the onset of an inflammatory process in the prone vessel and perivascular adipose tissue which has not yet been clarified and is still being investigated
Coronary artery bypass grafting is an effective treatment of coronary artery disease which has been shown to prolong survival Perioperative analysis of the myocardial metabolic profile helps to identify appropriate markers and metabolites associated with early myocardial damage This in turn helps to improve risk stratification by better understanding the mechanisms of the disease processes in order to prevent postoperative myocardial infarction and its associated complications Such indicators which are related to the diagnosis and severity of coronary artery disease as well as the prognosis of coronary artery bypass grafting have been separately studied before in the peripheral blood of patients with coronary artery disease in healthy vascular tissues such as mammary artery compared to atherosclerotic tissue from the coronary artery as well as in the epicardial adipose tissue intraoperatively
The aim of the proposed study is to investigate and evaluate metabolic factors and biomarkers preoperatively intraoperatively and postoperatively in patients undergoing coronary artery bypass grafting and their prognostic value regarding a the severity of coronary artery disease Gensini score ejection fraction acute coronary syndrome and b the outcome of surgery indications of myocardial damage and or infarction low cardiac output syndrome and use of intraortic balloon pump atrial fibrillation 30-day mortality
Coronary artery bypass grafting is an effective treatment of coronary artery disease which has been shown to prolong survival Perioperative analysis of the myocardial metabolic profile helps to identify appropriate markers and metabolites associated with early myocardial damage This in turn helps to improve risk stratification by better understanding the mechanisms of the disease processes in order to prevent postoperative myocardial infarction and its associated complications Such indicators which are related to the diagnosis and severity of coronary artery disease as well as the prognosis of coronary artery bypass grafting have been separately studied before in the peripheral blood of patients with coronary artery disease in healthy vascular tissues such as mammary artery compared to atherosclerotic tissue from the coronary artery as well as in the epicardial adipose tissue intraoperatively
The aim of the proposed study is to investigate and evaluate metabolic factors and biomarkers preoperatively intraoperatively and postoperatively in patients undergoing coronary artery bypass grafting and their prognostic value regarding a the severity of coronary artery disease Gensini score ejection fraction acute coronary syndrome and b the outcome of surgery indications of myocardial damage and or infarction low cardiac output syndrome and use of intraortic balloon pump atrial fibrillation 30-day mortality
Detailed Description:
This is a prospective study which will include 90 patients with diagnosed symptomatic coronary artery disease who are scheduled to undergo coronary artery bypass surgery at the Onassis Cardiac Surgery Center Patients with other cardiovascular diseases valvular pathologies or aortic diseases will not be included in the study
A Upon admission in hospital patients will be informed and will sign their consent to participate in the research protocol Subsequently a complete medical history will be obtained including risk factors comorbidities and medical treatment Gensini score of coronary artery disease severity ejection fraction and history of acute coronary syndrome will also be recorded
B Preoperatively a blood sample will be taken from a peripheral vein part of which will be stored in RNA preservation tubes and another part will be centrifuged in the Biochemistry Laboratory for plasma preservation
C Intraoperatively and in chronological order
Blood samples will be taken through the coronary sinus catheter just before initiating extracorporeal circulation divided into four parts 1 in RNA preservation tube 2 in a tube for plasma isolation 3 in a tube for direct biochemical analysis TnI NT-proBNP LDH and 4 in a blood gas analyzer for pO2 pCO2 SpO2 Lactate acid Hgb calculation
Tissue samples will be taken from the harvested internal mammary artery atheroma of the coronary vessel whenever possible and epicardial adipose tissue
Blood sample through the coronary sinus catheter immediately after extracorporeal circulation divided into two parts 1 in a tube for direct biochemical analysis and 2 in a blood gas analyzer for pO2 pCO2 SpO2 Lactate acid Hgb calculation
Simultaneously at the same time points blood samples will be taken from the radial or brachial artery before and after extracorporeal circulation and analyzed for blood gases
D Postoperatively a peripheral blood sample will be taken from the patient on the day of discharge one part will be stored in RNA preservation tubes and another part centrifuged in the Biochemistry Laboratory for plasma preservation In addition intraoperative data extracorporeal circulation duration aortic cross-clamp time and intervention outcome data maximum troponin value and corresponding time postoperative ejection fraction atrial fibrillation event intra-aortic pump placement ICU stay duration hospital stay duration 30-day mortality will be recorded
E All whole blood plasma and tissue samples will be immediately stored at -80C grouped for each case until sent to the Laboratory of Biological Chemistry at the University of Athens for detection and quantification of indicators such as extracellular matrix metalloproteinases MMP-2 MMP-9 TIMP1 TIMP2 cytokines IFNγ IL-2 IL-4 IL-5 IL-6 and microRNA expression
F After data collection statistical analysis and correlation of various parameters measured in the coronary vessel epicardial fat patients serum and blood from the coronary sinus will be performed 1 with the severity of coronary artery disease Gensini score and 2 with the short-term surgery outcome Differences in the expression of study parameters between the coronary artery and internal mammary artery of the same patient will also be highlighted These findings aim to identify new biomarkers of coronary artery disease and clarify the role of epicardial fat in the atheromatous process
A Upon admission in hospital patients will be informed and will sign their consent to participate in the research protocol Subsequently a complete medical history will be obtained including risk factors comorbidities and medical treatment Gensini score of coronary artery disease severity ejection fraction and history of acute coronary syndrome will also be recorded
B Preoperatively a blood sample will be taken from a peripheral vein part of which will be stored in RNA preservation tubes and another part will be centrifuged in the Biochemistry Laboratory for plasma preservation
C Intraoperatively and in chronological order
Blood samples will be taken through the coronary sinus catheter just before initiating extracorporeal circulation divided into four parts 1 in RNA preservation tube 2 in a tube for plasma isolation 3 in a tube for direct biochemical analysis TnI NT-proBNP LDH and 4 in a blood gas analyzer for pO2 pCO2 SpO2 Lactate acid Hgb calculation
Tissue samples will be taken from the harvested internal mammary artery atheroma of the coronary vessel whenever possible and epicardial adipose tissue
Blood sample through the coronary sinus catheter immediately after extracorporeal circulation divided into two parts 1 in a tube for direct biochemical analysis and 2 in a blood gas analyzer for pO2 pCO2 SpO2 Lactate acid Hgb calculation
Simultaneously at the same time points blood samples will be taken from the radial or brachial artery before and after extracorporeal circulation and analyzed for blood gases
D Postoperatively a peripheral blood sample will be taken from the patient on the day of discharge one part will be stored in RNA preservation tubes and another part centrifuged in the Biochemistry Laboratory for plasma preservation In addition intraoperative data extracorporeal circulation duration aortic cross-clamp time and intervention outcome data maximum troponin value and corresponding time postoperative ejection fraction atrial fibrillation event intra-aortic pump placement ICU stay duration hospital stay duration 30-day mortality will be recorded
E All whole blood plasma and tissue samples will be immediately stored at -80C grouped for each case until sent to the Laboratory of Biological Chemistry at the University of Athens for detection and quantification of indicators such as extracellular matrix metalloproteinases MMP-2 MMP-9 TIMP1 TIMP2 cytokines IFNγ IL-2 IL-4 IL-5 IL-6 and microRNA expression
F After data collection statistical analysis and correlation of various parameters measured in the coronary vessel epicardial fat patients serum and blood from the coronary sinus will be performed 1 with the severity of coronary artery disease Gensini score and 2 with the short-term surgery outcome Differences in the expression of study parameters between the coronary artery and internal mammary artery of the same patient will also be highlighted These findings aim to identify new biomarkers of coronary artery disease and clarify the role of epicardial fat in the atheromatous process
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None